is olympia semaglutide fda approved GLP-1 Agonists for Weight Loss Semaglutide FDA Approval vs Compounded

(XLSX) S5 Data

Fatigue : Some individuals report feeling more tired than usual, particularly during the first few weeks of treatment

Each mL contains 100 units of insulin aspart and the inactive ingredients: disodium hydrogen phosphate dihydrate (1.25 mg), glycerin (16.0 mg), metacresol (1.72 mg), phenol (1.50 mg), sodium chloride (0.58 mg), zinc (19.6 mcg), and Water for Injection, USP

doi: 10.1038/s41598-020-80603-8 165 ZaccardiFKloeckerDEBuseJBMathieuCKhuntiKDaviesMJ

However, those benefits come at a significant financial cost, with annual treatment expenses typically ranging from $12,000 to $16,000 per patient. GLP1 coverage is one of the most consequential benefit decisions employers will face in 2026

Notably, the FDA approved a new indication for the use of Wegovy(R) to reduce the risk of serious cardiovascular events in patients with cardiovascular disease (CVD) & overweight or obesity in March 2024